Trial Profile
Safety and efficacy of ibandronate in Japanese patients with osteoporosis: A post-marketing, observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 19 Jan 2018 New trial record